Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms

• Hiroko Sakurai,
• Yuka Harada,
• Yosuke Ogata,
• Yuki Kagiyama,
• Naoki Shingai,
• Noriko Doki,
• Kazuteru Ohashi,
• Toshio Kitamura,
• Norio Komatsu,
• Hironori Harada

Affiliations

Hiroko Sakurai

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan

Yuka Harada

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan; Department of Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan

Yosuke Ogata

Department of Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan

Yuki Kagiyama

Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan

Naoki Shingai

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan

Noriko Doki

Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan

Kazuteru Ohashi

Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan

Toshio Kitamura

Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Norio Komatsu

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan

Hironori Harada

Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan; Hironori Harada, Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan;